Clinical Trial Update: Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pre-delivery azithromycin to prevent neonatal sepsis and death has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Sepsis

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Neonatal SEPSIS | Phase 3 | Status: COMPLETED